Monash IVF Group Limited (MVF.AX) Stock Analysis & Winston Score
Monash IVF Group is an Australian fertility clinic company that helps people have babies through in vitro fertilization (IVF) and related treatments. Its core services include IVF cycles, fertility assessments, ultrasound diagnostics, and genetic testing of embryos. The company operates across Australia and Malaysia, serving patients who need medical assistance to conceive. Monash IVF makes money by charging patients and private health insurers for each fertility treatment or diagnostic service performed. It runs around 30 clinic locations, primarily in Australia, making it one of the larger fertility clinic networks in the country. The company benefits from a degree of scale and specialist medical expertise that is difficult to replicate quickly, but it faces real competition from other fertility groups like Virtus Health. The key growth driver is rising demand for fertility services as more people delay having children, though the business is sensitive to any changes in government rebates or private health insurance coverage that help patients afford treatment.
Winston Score: 41/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (8/30)
- Growth: Weak (3/20)
- Cash Flow: Strong (7/10)
- Stability: Good (5/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: 0.74 AUD
Market Cap: 290M AUD
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: Australian Securities Exchange

